News
MapLight Therapeutics today announced the initiation of a Phase 2 study to evaluate the efficacy, safety and tolerability of ML-007C-MA, an investigational novel M1/M4 agonist, as a potential ...
Plasma p-tau181 is a promising biomarker that can help identify Alzheimer's disease pathology and distinguish those who are at risk for conversion to dementia.
New research finds hormone therapy could protect your brain from Alzheimer’s, but only if you start soon after menopause.
DENVER — Thousands are expected to gather at Denver’s City Park on Saturday for the Walk to End Alzheimer’s. A fundraising ...
Alzheimer's disease is a progressive brain disorder that causes memory loss, cognitive decline, changes in behavior and personality ...
“Starting hormone replacement therapy early may give the brain some protection, but if a woman already has Alzheimer’s or ...
Caregivers of Alzheimer’s disease patients and others are invited to attend a free conference in Charleston next month. The ...
September is World Alzheimer's Month and St. Lawrence County officials hope to raise further awareness regarding the disease.
Thousands of people across Ireland are affected by dementia, yet more more of a particular fruit might help stave off this devastating condition. The cruel symptoms of the disease include memory loss, ...
The Maine Beaches Walk to End Alzheimer’s will take place in York Beach on Sept. 27, followed by the Seacoast Walk to End ...
A senior Novo Nordisk executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results